Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rakovina Therapeutics Inc (RKV.VN)

Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3,066
  • Shares Outstanding, K 21,148
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,073 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.25
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.62
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.56
  • Most Recent Earnings $-0.08 on 11/28/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    TSX Biotechnology

    TSX Bottom 100 Stocks

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.115 +30.43%
on 01/20/26
0.240 -37.50%
on 02/04/26
+0.035 (+30.43%)
since 01/16/26
3-Month
0.085 +76.47%
on 12/24/25
0.240 -37.50%
on 02/04/26
+0.010 (+7.14%)
since 11/18/25
52-Week
0.085 +76.47%
on 12/24/25
1.850 -91.89%
on 02/19/25
-1.650 (-91.67%)
since 02/18/25

Most Recent Stories

More News
Junior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving Lives

The urgent need for innovative technologies to accelerate the development of life-saving %Cancer therapies has never been more critical. With millions of lives and billions of dollars at stake, the potential...

MRK : 121.66 (+0.07%)
NVS : 165.38 (-0.48%)
RHHBY : 59.6900 (-0.68%)
AZN : 208.67 (-0.39%)
BMRN : 61.83 (+3.14%)
KTRA : 0.2154 (-6.31%)
XBIT : 2.41 (+2.99%)
RKV.VN : 0.150 (+3.45%)
Stocks in play: Rakovina Therapeutics Inc.

Will be hosting an informational webinar on Wednesday, April 3. Rakovina Therapeutics Inc. shares V.RKV ...

RKV.VN : 0.150 (+3.45%)
Rakovina Therapeutics Announces Results from Annual General Meeting

VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company...

RKV.VN : 0.150 (+3.45%)
Rakovina Therapeutics Inc. Announces Q1 2022 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company...

RKV.VN : 0.150 (+3.45%)
Rakovina Therapeutics Inc. Announces 2021 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company...

RKV.VN : 0.150 (+3.45%)
InvestmentPitch Media Video Discusses Rakovina Therapeutics and its Presentation of Preclinical Data Supporting Potential Broad Anticancer Activity of kt-4000 Series at the American Association of Cancer Research Annual General Meeting

VANCOUVER, British Columbia, April 14, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV:RKV), a biopharmaceutical company committed to advancing...

RKV.VN : 0.150 (+3.45%)
Rakovina Therapeutics Presents Preclinical Data Supporting Potential Broad Anticancer Activity of kt-4000 Series at the American Association of Cancer Research (AACR) Annual General Meeting

VANCOUVER, British Columbia, April 12, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company...

RKV.VN : 0.150 (+3.45%)
Rakovina Therapeutics to Present Abstract at the 2022 AACR Special Conference – Sarcomas

Company will highlight new data with kt-3000 lead candidates as a potential treatment for Ewing sarcoma...

RKV.VN : 0.150 (+3.45%)
Rakovina Therapeutics to Present Abstract at the 2022 Annual Meeting of the American Association of Cancer Research (AACR)

VANCOUVER, British Columbia, March 09, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company...

RKV.VN : 0.150 (+3.45%)
The Power Play by The Market Herald Releases New Interviews with Nextech AR, i-80 Gold, Kidoz Inc., Rakovina Therapeutics, Prophecy DeFi, and Saturn Oil & Gas Discussing Their Latest Press Releases

VANCOUVER, BC / ACCESSWIRE / November 16, 2021 / The Power Play by The Market Herald has announced the release of new interviews with Nextech AR, i-80 Gold, Kidoz Inc., Rakovina Therapeutics, Prophecy...

IAU.TO : 2.63 (+2.33%)
NTAR.CN : 0.1500 (-3.23%)
PDFI.CN : 0.3800 (+8.57%)
SOIL.VN : 2.270 (+3.18%)
KIDZ.VN : 0.360 (+2.86%)
RKV.VN : 0.150 (+3.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and...

See More

Key Turning Points

3rd Resistance Point 0.158
2nd Resistance Point 0.157
1st Resistance Point 0.153
Last Price 0.150
1st Support Level 0.148
2nd Support Level 0.147
3rd Support Level 0.143

See More

52-Week High 1.850
Fibonacci 61.8% 1.176
Fibonacci 50% 0.968
Fibonacci 38.2% 0.759
Last Price 0.150
52-Week Low 0.085

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar